Best Practices

A whiteboard saying transition
Investment
From Series A to B: Navigating the transition from promise to proofFrom Series A to B: Navigating the transition from promise to proof

Investors at LSX Investival discuss how, after securing Series A funding, biotech companies should begin to lay the groundwork for Series B financing.

byMillie Nelson
Nov 20, 2024
|
1 Min Read
thumbnail
Investment
What’s your secret sauce? VC’s on what makes a compelling pitchVC’s on what makes a compelling pitch
byMillie Nelson
Oct 24, 2024
1 Min Read
Green leaf with sustainability symbol
Business Strategy
The sustainability series: Reflect, rethink, and reformThe sustainability series: Reflect, rethink, and reform
byMillie Nelson
Oct 11, 2024
1 Min Read
Wooden block with people icons
Partnering
Want to be a partner of choice? Distinguish yourself in the spaceWant to be a partner of choice? Distinguish yourself in the space
byMillie Nelson
Sep 25, 2024
1 Min Read
thumbnail
Partnering
To be truly great you need to partner, says J&JTo be truly great you need to partner, says J&J
byMillie Nelson
Sep 25, 2024
1 Min Read
People making business deals
Partnering
Prometheus and Merck: Under the bonnet of the largest pre-Phase III M&A dealUnder the bonnet of the largest pre-Phase III M&A deal
byMillie Nelson
Sep 25, 2024
1 Min Read
Abu Dhabi Global Healthcare Week 2024
Partnering
BioNTech: Partnerships are key to deliver drugs at scale
BioNTech: Partnerships are key to deliver drugs at scale
May 20, 2024
|
1 Min Read
byMillie Nelson
different coloured smoke
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
1 Min Read
byMillie Nelson
Wedding rings
Partnering
Perfect match: Picking your CDMO is like a marriage, says Bayer
Picking your CDMO is like a marriage, says Bayer
Apr 11, 2024
|
1 Min Read
byMillie Nelson
BIO-Europe Spring
Partnering
Competitor today, friend tomorrow: Why partnering is critical for biopharma success
Why partnering is critical for biopharma success
Apr 5, 2024
|
1 Min Read
byMillie Nelson

News from APAC

Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blastEyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
byRichard Daverman
Nov 18, 2024
5 Min Read
Money
Investment
Eyes on Asia: Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScriptEyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
byRichard Daverman
Nov 5, 2024
3 Min Read
Reverse arrow
Partnering
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchangeEddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
byRichard Daverman
Oct 31, 2024
3 Min Read

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated